215 related articles for article (PubMed ID: 34750323)
41. Prognostic impact of renal impairment and sodium imbalance in patients undergoing transjugular intrahepatic portosystemic shunting for the prevention of variceal rebleeding.
Schepke M; Roth F; Koch L; Heller J; Rabe C; Brensing KA; Schiedermaier P; Schild HH; Sauerbruch T
Digestion; 2003; 67(3):146-53. PubMed ID: 12853726
[TBL] [Abstract][Full Text] [Related]
42. Conversion of failed transjugular intrahepatic portosystemic shunt to distal splenorenal shunt in patients with Child A or B cirrhosis.
Selim N; Fendley MJ; Boyer TD; Galloway JR; Branum GD
Ann Surg; 1998 Apr; 227(4):600-3. PubMed ID: 9563552
[TBL] [Abstract][Full Text] [Related]
43. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score.
Ferral H; Gamboa P; Postoak DW; Albernaz VS; Young CR; Speeg KV; McMahan CA
Radiology; 2004 Apr; 231(1):231-6. PubMed ID: 14990811
[TBL] [Abstract][Full Text] [Related]
44. Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice.
Bucsics T; Schoder M; Goeschl N; Schwabl P; Mandorfer M; Diermayr M; Feldner M; Riedl F; Bauer D; Angermayr B; Cejna M; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Karner J; Karnel F; Reiberger T
Dig Liver Dis; 2017 Dec; 49(12):1360-1367. PubMed ID: 28869158
[TBL] [Abstract][Full Text] [Related]
45. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
[TBL] [Abstract][Full Text] [Related]
46. Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS.
Al Sibae MR; Cappell MS
Dig Dis Sci; 2011 Apr; 56(4):977-87. PubMed ID: 20844956
[TBL] [Abstract][Full Text] [Related]
47. Serum cholesterol predicts transplant-free survival in cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt.
Ballester MP; Lluch P; Tosca J; Capilla M; Gómez C; Moreno O; Jordán-Iborra C; Sunsundegui P; Argemi J; Guijarro J; Mínguez M
Dig Liver Dis; 2021 Dec; 53(12):1596-1602. PubMed ID: 34052179
[TBL] [Abstract][Full Text] [Related]
48. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
Kraglund F; Jepsen P; Amanavicius N; Aagaard NK
Scand J Gastroenterol; 2019 Jul; 54(7):899-904. PubMed ID: 31203699
[No Abstract] [Full Text] [Related]
49. Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis.
Heinzow HS; Lenz P; Köhler M; Reinecke F; Ullerich H; Domschke W; Domagk D; Meister T
World J Gastroenterol; 2012 Oct; 18(37):5211-8. PubMed ID: 23066315
[TBL] [Abstract][Full Text] [Related]
50. Hip Fractures in Patients With Liver Cirrhosis: Worsening Liver Function Is Associated with Increased Mortality.
Hundersmarck D; Groot OQ; Schuijt HJ; Hietbrink F; Leenen LPH; Heng M
Clin Orthop Relat Res; 2022 Jun; 480(6):1077-1088. PubMed ID: 34978539
[TBL] [Abstract][Full Text] [Related]
51. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
52. Prognosis value of serum chloride on 1-year mortality in cirrhotic patients receiving transjugular intrahepatic portosystemic shunt.
Cheng J; Huang K; Mou JL; Lao YJ; Feng JH; Hu F; Lin ML; Maimaitiaishan T; Shang J; Lin J
J Formos Med Assoc; 2023 Sep; 122(9):911-921. PubMed ID: 36878767
[TBL] [Abstract][Full Text] [Related]
53. [Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in liver cirrhosis: intended population and timing].
Lyu Y; Han GH; Fan DM
Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):402-407. PubMed ID: 28763854
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of transjugular intrahepatic portosystemic shunt in difficult-to-manage hydrothorax in cirrhosis.
Jindal A; Mukund A; Kumar G; Sarin SK
Liver Int; 2019 Nov; 39(11):2164-2173. PubMed ID: 31356712
[TBL] [Abstract][Full Text] [Related]
55. Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic Shunts.
Shoreibah MG; Mahmoud K; Aboueldahab NA; Vande Lune P; Massoud M; Bae S; El Khudari H; Gunn AJ; Abdel Aal AK
J Vasc Interv Radiol; 2019 Feb; 30(2):154-161. PubMed ID: 30717946
[TBL] [Abstract][Full Text] [Related]
56. Transjugular intrahepatic portosystemic shunt treatment of variceal bleeding in an unselected patient population.
Rosenqvist K; Sheikhi R; Nyman R; Rorsman F; Sangfelt P; Ebeling Barbier C
Scand J Gastroenterol; 2018 Jan; 53(1):70-75. PubMed ID: 28990812
[TBL] [Abstract][Full Text] [Related]
57. The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls.
Lee HL; Lee SW
Clin Mol Hepatol; 2022 Apr; 28(2):121-134. PubMed ID: 34571587
[TBL] [Abstract][Full Text] [Related]
58. Transjugular Intrahepatic Portosystemic Shunt Creation and Variceal Coil or Plug Embolization Ineffectively Attain Gastric Variceal Decompression or Occlusion: Results of a 26-Patient Retrospective Study.
Lakhoo J; Bui JT; Lokken RP; Ray CE; Gaba RC
J Vasc Interv Radiol; 2016 Jul; 27(7):1001-11. PubMed ID: 27106732
[TBL] [Abstract][Full Text] [Related]
59. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
[TBL] [Abstract][Full Text] [Related]
60. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study.
Xiao T; Chen L; Chen W; Xu B; Long Q; Li R; Li L; Peng Z; Fang D; Wang R
J Clin Gastroenterol; 2011 Aug; 45(7):643-50. PubMed ID: 21301360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
